New Canaan rolls past Norwalk
Orange was the new black at Dunning Field Friday night.
But as far as this series goes, it was the same old result.
On the strength of a dominant first half and a season-high 211 rushing yards, New Canaan rolled to a 39-7 victory over Norwalk in a game that was live-streamed on MSGVarsity.com and dedicated to the Multiple Myeloma Research Foundation.
The Rams (4-1) scored on their first four possessions and also got a 39-yard interception return from senior Casey Oullette to build a 27-0 halftime lead.
New Canaan was so impressive in the first two quarters that it actually ran more plays (35) than Norwalk (32) had yards.
In more than doubling the yards (274-175) and first downs (23-9) by the Bears (1-4), the Rams had little trouble in upping their all-time series edge to 28-14-1.
"This is an important point in the season for us and being that it was for MMRF made it a special game," said senior Grady Lynch, who caught a 6-yard touchdown pass from Nick Cascione on a jet sweep option pass to cap the Rams' first scoring drive of the night midway through the first quarter.
"There's still stuff to work on, but we looked good and overall it was a great showing. Norwalk has a good offense, and we were able to hold them."
Neal Koller kicked field goals of 31 and 32 yards in the second quarter, and FRank Cognetta added a 1-yard touchdown run late in the first half.
New Canaan would add to the cushion midway through the third quarter on a 27-yard pass from Teddy Bossidy to Andrew Read.
Tomar Joseph, who finished with 65 yards on 10 carries, finally got the Bears on the board with 10:38 left in the fourth quarter courtesy of a 1-yard plunge.
The Rams quickly responded, marching 62 yards on eight plays and ultimately getting a 5-yard pass from Cascione to Cole Turpin for the game's final score with 7 minutes remaining.
A number of players, coaches and cheerleaders incorporated orange into their clothing, and fans were given leis of the same color as a way to raise awareness for Myeloma, the second most common blood cancer.